Items tagged with TB care
US: Undocumented immigrants face a unique set of risks from TB treatment: is this just? (post)
Consider a hypothetical scenario: Rosa, a 35-year-old healthy woman, visits a primary care physician at a community clinic for a routine checkup. She immigrated to the United States one year ago from Mexico, a country with a higher prevalence of tuberculosis (27 cases per 100,000 people) [1] than the US [2]. The primary care physician recommends screening for latent tuberculosis infection (LTBI) based on established guidelines. Rosa’s purified protein derivative (PPD) skin test is positive, and she is started on isoniazid (isonicotinylhydrazide or INH). While taking it, she develops jaundice and lower extremity edema and is admitted to the hospital. She becomes critically ill and is found to have fulminant hepatic failure—acute liver failure—an iatrogenic consequence of INH treatment. A liver transplant would save her life, but Rosa is deemed not to be a good candidate for transplant because she is poor, uninsured, and undocumented. She dies of liver failure and sepsis. Here we consider the unique risks that undocumented immigrants incur when accepting LTBI therapy and the physician’s duty to disclose these risks, and we present policy and clinical solutions that would protect public health without placing undue burden on undocumented immigrants.
Use of transnational services to prevent treatment interruption in TB-infected persons who leave the United States (post)
Abstract
Monitoring therapy adherence of TB patients by using video-enabled electronic devices (post)
Abstract
Preliminary favorable outcome for medically and surgically managed extensively drug-resistant tuberculosis in France, 2009–2014 (post)
Abstract
Does tuberculosis threaten our ageing populations? (post)
Abstract
The right dose, the right chance: India's battle with drug-resistant TB (post)
Every Monday Dr. Zarir Udwadia runs a free tuberculosis clinic at P.D. Hinduja hospital in Mumbai, the forefront of India’s drug-resistant epidemic.
The rocky road to destigmatising tuberculosis (post)
According to the WHO 2014 Global Tuberculosis Report an estimated 9 million new cases of tuberculosis occurred in 2013, a worrisome increase from the 8·6 million cases estimated for 2012.
India: Drug-resistant TB and a promising drug (post)
World TB Day commemoration events for 2016 have just concluded. The Ministry of Health and Family Welfare announced that bedaquiline, the first new TB drug in over 40 years, will be now available in India. It had been given accelerated approval by the U.S. Food and Drug Administration in December 2012. Announcing its availability, the Ministry indicated it would be available only at six sites; in the first lot, only 600 doses will come.
Page 10 of 44 · Total posts: 0
←First 9 10 11 Last→